# Meridian Corp: overview MRBK · Nasdaq · CIK 1750735 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mrbk.md) · [Financials](/companies/mrbk/financials.md) · [Filings](/companies/mrbk/filings.md) · [Insiders](/companies/mrbk/insiders.md) Latest reported revenue: [$1.7m](/filings/0001750735-26-000063.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001750735-26-000063). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.4](/filings/0001750735-25-000077.md) | [1.5 d](/filings/0001750735-26-000009.md) | [1.5](/filings/0001750735-26-000050.md) | [1.5](/filings/0001750735-26-000063.md) | [1.6](/filings/0001750735-25-000077.md) | [1.7 d](/filings/0001750735-26-000009.md) | [1.7](/filings/0001750735-26-000050.md) | [1.7](/filings/0001750735-26-000063.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [327.8%](/filings/0001750735-25-000077.md) | [366.8% d](/filings/0001750735-26-000009.md) | [156.3%](/filings/0001750735-26-000050.md) | [374.8%](/filings/0001750735-26-000063.md) | [413.6%](/filings/0001750735-25-000077.md) | [428.0% d](/filings/0001750735-26-000009.md) | [116.0%](/filings/0001750735-26-000050.md) | [340.4%](/filings/0001750735-26-000063.md) | | Diluted EPS | $ per share | [0.42](/filings/0001750735-25-000077.md) | not reported | [0.21](/filings/0001750735-26-000050.md) | [0.49](/filings/0001750735-26-000063.md) | [0.58](/filings/0001750735-25-000077.md) | not reported | [0.17](/filings/0001750735-26-000050.md) | [0.48](/filings/0001750735-26-000063.md) | | Free cash flow | $m | [29.5 d](/filings/0001750735-25-000077.md) | [(1.1) d](/filings/0001750735-26-000009.md) | [17.9](/filings/0001750735-26-000050.md) | [(12.7) d](/filings/0001750735-26-000063.md) | [24.0 d](/filings/0001750735-25-000077.md) | [(6.6) d](/filings/0001750735-26-000009.md) | [2.6](/filings/0001750735-26-000050.md) | [(1.4) d](/filings/0001750735-26-000063.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [4.7](/filings/0001750735-24-000019.md) | [4.9](/filings/0001750735-25-000011.md) | [5.7](/filings/0001750735-26-000009.md) | [6.3](/filings/0001750735-26-000009.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | [461.2%](/filings/0001750735-24-000019.md) | [268.7%](/filings/0001750735-25-000011.md) | [285.0%](/filings/0001750735-26-000009.md) | [345.7%](/filings/0001750735-26-000009.md) | | Diluted EPS | $ per share | [2.87](/filings/0001750735-23-000024.md) | [1.79](/filings/0001750735-24-000019.md) | [1.16](/filings/0001750735-25-000011.md) | [1.45](/filings/0001750735-26-000009.md) | [1.89](/filings/0001750735-26-000009.md) | | Free cash flow | $m | [160](/filings/0001750735-23-000024.md) | [81.8](/filings/0001750735-24-000019.md) | [17.0](/filings/0001750735-25-000011.md) | [9.0](/filings/0001750735-26-000009.md) | [22.6](/filings/0001750735-26-000009.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mrbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $13.8m | 690,544 | | Added +132,012 | | [STRATEGIC VALUE BANK PARTNERS LLC](/funds/1904067.md) | 2026-06-30 | $13.0m | 651,298 | | Unchanged | | [Fourthstone LLC](/funds/1767803.md) | 2026-06-30 | $10.8m | 538,390 | | Reduced −636,911 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $10.0m | 497,805 | | Added +63,803 | | [FIRST MANHATTAN CO. LLC.](/funds/728083.md) | 2026-06-30 | $8.8m | 437,696 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.7m | 434,281 | | Reduced −52,561 | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $7.7m | 382,533 | | Added +13,200 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.6m | 280,264 | | Added +67,202 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $5.2m | 258,339 | | Added +65,657 | | [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $4.4m | 217,353 | | Added +164,682 | ## Recent filings [All 358 filings](/companies/mrbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 16:10 ET | [8-K](/filings/0001750735-26-000070.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001750735-26-000070 | | 2026-08-07 | 10:23 ET | [10-Q](/filings/0001750735-26-000063.md) | Quarterly report, period 2026-06-30 | 0001750735-26-000063 | | 2026-07-30 | 17:05 ET | [8-K](/filings/0001750735-26-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001750735-26-000059 | | 2026-07-23 | 16:58 ET | [8-K](/filings/0001750735-26-000056.md) | 7.01 Regulation FD disclosure | 0001750735-26-000056 | | 2026-05-29 | 14:38 ET | [8-K](/filings/0001750735-26-000053.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001750735-26-000053 | | 2026-05-11 | 12:22 ET | [10-Q](/filings/0001750735-26-000050.md) | Quarterly report, period 2026-03-31 | 0001750735-26-000050 | | 2026-05-04 | 16:32 ET | [8-K/A](/filings/0001750735-26-000046.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001750735-26-000046 | | 2026-04-27 | 16:47 ET | [8-K](/filings/0001750735-26-000039.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001750735-26-000039 | | 2026-04-23 | 16:05 ET | [8-K](/filings/0001750735-26-000036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001750735-26-000036 | | 2026-04-23 | 15:18 ET | [8-K](/filings/0001750735-26-000033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001750735-26-000033 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001750735-26-000009.md), filed Mar 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cfd889ea-de15-4b36-9a0f-3cc62db6b40a) ## About the filer - CIK: 1750735 - Tickers: MRBK - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: PA - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.